Opdivo Approved by FDA for Small Cell Lung Cancer

09:28 EDT 20 Aug 2018 | Pharmaceutical Processing

News
Opdivo is the first Immuno-Oncology treatment approved for small cell lung cancer patients who received platinum-based chemotherapy and at least one other line of therapy.
Contributed Author: 
Bristol-Myers Squibb Company
Topics: 
Oncology

Original Article: Opdivo Approved by FDA for Small Cell Lung Cancer

More From BioPortfolio on "Opdivo Approved by FDA for Small Cell Lung Cancer"